ESC Premium Access

Upfront triple combination therapy with ambrisentan, tadalafil and subcutaneous treprostinil in incident patients with severe pulmonary arterial hypertension

Congress Presentation

About the speaker

Professor Michele D'Alto

AORN Ospedali dei Colli - Monaldi Hospital, Naples (Italy)
4 presentations
3 followers

5 more presentations in this session

Validation of ESC/ERS 2015 guidelines risk score in patients with scleroderma associated pulmonary arterial hypertension (SSc-PAH)

Speaker: Doctor H. Fayed (London, GB)

Thumbnail

Blood viscosity and its relevance to the diagnosis and management of pulmonary hypertension: a new elephant in the cathlab

Speaker: Doctor A. Kempny (London, GB)

Thumbnail

Efficacy and safety of selexipag in pulmonary arterial hypertension (PAH) patients with and without significant cardiovascular (CV) comorbidities

Speaker: Professor S. Rosenkranz (Cologne, DE)

Thumbnail

Waitlist outcomes for Eisenmengers patients listed for bilateral sequential lung transplant or heart-lung transplant

Speaker: Doctor K. Kearney (Sydney, AU)

Thumbnail

Efficacy of pulmonary hypertension-targeted drugs for severe chronic thromboembolic pulmonary hypertension

Speaker: Doctor K. Takeuchi (Tokyo, JP)

Thumbnail

Access the full session

New concepts in pulmonary hypertension

Speakers: Professor M. D'Alto, Doctor H. Fayed, Doctor A. Kempny, Professor S. Rosenkranz, Doctor K. Kearney...
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations